Shares of Cannabis Science Inc. (PINK: CBIS), a development stage company engaged in the business of developing pharmaceutical grade medical cannabis products, are soaring in trading today.
At last check, CBIS shares were trading 30.43% higher at $0.0900 on above average volume of 48.17 million. The stock hit an intra-day high of $0.10 today. CBIS has now gained more than 91% in the last three trading sessions.
CBIS shares are soaring after the company today provided corporate guidance on preclinical initiative and recent corporate developments for its shareholders. Dr. Robert Melamede, President and CEO of Cannabis Science, said that over the past 3 quarters, CBIS has successfully initiated a strong biomedical research program for the scientific investigation of its lead compound to demonstrate the anti-viral and anti-oncogenic properties based on multiple signaling pathways of cannabinoid therapeutics.
Shares of Santo Mining Corp. (OTC: SANP), a Dominican Republic-based junior mineral exploration and development company focusing on gold production opportunities, are rallying in trading today.
At last check, SANP shares were trading 16.13% higher at $1.08 on above average volume of 2.58 million. The stock hit an intra-day high of $1.08 in trading today. In the last three trading sessions, SANP shares have gained 34.37%.
SANP shares are soaring in trading today after the company said that it is mobilizing its exploration strike team for an intensive 90 days of exploration on its precious and base metal claims in the mineral rich Hispaniola Gold Copper Arc in central Dominican Republic.
Shares of Amarantus BioSciences Inc. (OTC: AMBS), a development-stage biotechnology company engaged in the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI), and other human diseases, are seeing a huge rally in trading today.
At last check, AMBS shares were trading 39.44% higher at $0.0502 on above average volume of 40.55 million.
AMBS shares are soaring in trading today after the company announced it outlined terms for NuroPro Parkinson’s blood test joint venture with Rainbow BioSciences, a biotech subsidiary of Rainbow Coral Corp.
Recent Comments